National Institute for Communicable Disease Control and Prevention

Facility Details

Region
Western Pacific

GLP Lead
WHO

GLP Compliance Progress

Status 1. Site Development

GLP Compliance Target 2019 Q4

Product Testing

IRS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

LLINS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

SPACE SPRAYS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

LARVICIDES

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

TOPICAL REPELLENTS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

GENETICALLY MODIFIED MOSQUITOES

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

Capacity and Features

Number of huts
0

Style of Huts
TBC

Any Other Facilities
TBC

Laboratory Strains
- Strain Names & Species

An.sinensis (SS);
Cx. pipiens pallens (3 strains: 2 SS, 1 RR;
Cx. tritaeniorhynchus (SS);
Ae. aegypti (SS);
Ae. albopictus (SS).

Wild Populations (and Resistance Profiles) - Species

Aedes aegypti (2 strains);
Aedes albopictus (3 strains).

Hut testing possible in the following months of the year

We do not currently have confirmation on this facilities time-of-year capabilities. Please use contact details below and a relevant contact will be able to support further.

Village Scale Trials possible in the following months of the year

We do not currently have confirmation on this facilities time-of-year capabilities. Please use contact details below and a relevant contact will be able to support further.

Contact Details

Contact
Liu Qiyong

Phone Number
TBC

Email Address
liuqiyong@icdc.cn

Website
http://www.chinacdc.cn